This program is supported by an independent educational grant from Amicus Therapeutics. This education program is designed for healthcare professionals globally (excluding the USA).
Who Should Attend?
This program is designed for global healthcare professionals involved in the diagnosis and management of Pompe disease, including:
- Neuromuscular Specialists
- Geneticists
- Neurologists
- Lysosomal Disease Specialists
- Respiratory Physicians, Genetic
- Counselors, Pediatricians,
- Other healthcare professionals involved in Pompe Disease
Speaker
Kevin Annesley
A patient advocate with the Pompe Support Network. Since his diagnosis in 2008, Mr Annesley has participated in several clinical trials and serves as a Community Advisory Board (CAB) member for the International Pompe Association (IPA).
Program Schedule: Full Series
Module 1 – Diagnosing Diverse LOPD Phenotypes
Recognizing respiratory-only, axial-dominant, and presymptomatic presentations; applying phenotype-specific testing triggers and coordinating multidisciplinary referrals.
Please click here to access Module 1.
Module 2 – Monitoring Subclinical Progression
Integrating muscle MRI, diaphragm ultrasound, and digital activity data to detect early decline and individualize therapy adjustments in “stable” LOPD.
Please click here to access Module 2.
Module 3 – Applying Triple-S to Treatment Decisions
Using the European Triple-S framework and comparative evidence to guide therapy initiation, transitions, and shared care planning.
Please click here to access Module 3.
Module 4 – Expert Q&A: Real-World Challenges in LOPD Care
Faculty responses to HCP-submitted questions on early diagnosis, multimodal monitoring, shared decision-making, and navigating emerging therapies.
Please click here to access Module 4.
Interview with Patient Advocate (Current Module)
Faculty Disclosure Statement / Conflict of Interest
In compliance with EBAC guidelines, all speakers/ chairpersons participating in this programme have disclosed or indicated potential conflicts of interest which might cause a bias in the presentations.
The Organizing Committee/Course Director is responsible for ensuring that all potential conflicts of interest relevant to the event are declared to the audience prior to the CE activities.
Kevin Annesley has no financial interests, relationships, or affiliations in relation to this activity.
Participation Costs
There is no cost to participate in this program.
System Requirements
Mobile device (e.g., large-format smart phone; laptop or tablet computer) or desktop computer with a video display of at least 1024 × 768 pixels at 24-bit color depth, capable of connecting to the Internet at broadband or faster speeds, with a current version Internet browser and popular document viewing software (e.g., Microsoft Office, PDF viewer, image viewer) installed. Support for streaming or downloadable audio-visual materials (e.g., streaming MP4, MP3 audio) in hardware and software may be required to view, review, or participate in portions of the program.
Disclaimer
This activity is intended for educational purposes only and does not establish a standard of care or replace clinical judgment. Any therapeutic or diagnostic strategies discussed must be evaluated in the context of each patient’s clinical circumstances, risks, and current evidence.
Learners should consult authoritative clinical guidelines and approved product information when considering treatment decisions.
All materials are used with permission. The views expressed are those of the faculty and do not necessarily reflect those of the accredited providers, MedAll, or any supporters.
Content is accurate as of the date of release.